Adverse effects associated with SonoVue® use

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Conventional ultrasonography (US) has limited accuracy in the detection and characterisation of solid focal liver lesions (FLL). Contrast-enhanced ultrasound (CEUS) significantly improves the diagnostic performance of US in the assessment of FLL. Rare reports of serious adverse events have been reported with CEUS. The rates of adverse reactions reported from the use of ultrasound contrast agents seem comparable to, or lower than, those observed for other imaging modalities that use contrast agents such as computed tomography and magnetic resonance imaging. Improved diagnostic results and diagnostic confidence achieved in conventional CEUS studies of the liver and during the investigational use in the intraoperative CEUS exploration appear to justify the use of this promising modality.

Original languageEnglish
Pages (from-to)399-401
Number of pages3
JournalExpert Opinion on Drug Safety
Volume4
Issue number3
DOIs
Publication statusPublished - May 2005

Fingerprint

Contrast Media
Liver
Ultrasonography
Tomography
Magnetic Resonance Imaging
contrast agent BR1

Keywords

  • Contrast-enhanced ultrasound (CEUS)
  • Hepatocellular carcinoma
  • Intraoperative ultrasonography
  • Liver cirrhosis
  • Liver metastases
  • Liver tumour

ASJC Scopus subject areas

  • Pharmacology

Cite this

Adverse effects associated with SonoVue® use. / Torzilli, Guido.

In: Expert Opinion on Drug Safety, Vol. 4, No. 3, 05.2005, p. 399-401.

Research output: Contribution to journalArticle

@article{3b47d733362b407ba90d697ec297a9cb,
title = "Adverse effects associated with SonoVue{\circledR} use",
abstract = "Conventional ultrasonography (US) has limited accuracy in the detection and characterisation of solid focal liver lesions (FLL). Contrast-enhanced ultrasound (CEUS) significantly improves the diagnostic performance of US in the assessment of FLL. Rare reports of serious adverse events have been reported with CEUS. The rates of adverse reactions reported from the use of ultrasound contrast agents seem comparable to, or lower than, those observed for other imaging modalities that use contrast agents such as computed tomography and magnetic resonance imaging. Improved diagnostic results and diagnostic confidence achieved in conventional CEUS studies of the liver and during the investigational use in the intraoperative CEUS exploration appear to justify the use of this promising modality.",
keywords = "Contrast-enhanced ultrasound (CEUS), Hepatocellular carcinoma, Intraoperative ultrasonography, Liver cirrhosis, Liver metastases, Liver tumour",
author = "Guido Torzilli",
year = "2005",
month = "5",
doi = "10.1517/14740338.4.3.399",
language = "English",
volume = "4",
pages = "399--401",
journal = "Expert Opinion on Drug Safety",
issn = "1474-0338",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Adverse effects associated with SonoVue® use

AU - Torzilli, Guido

PY - 2005/5

Y1 - 2005/5

N2 - Conventional ultrasonography (US) has limited accuracy in the detection and characterisation of solid focal liver lesions (FLL). Contrast-enhanced ultrasound (CEUS) significantly improves the diagnostic performance of US in the assessment of FLL. Rare reports of serious adverse events have been reported with CEUS. The rates of adverse reactions reported from the use of ultrasound contrast agents seem comparable to, or lower than, those observed for other imaging modalities that use contrast agents such as computed tomography and magnetic resonance imaging. Improved diagnostic results and diagnostic confidence achieved in conventional CEUS studies of the liver and during the investigational use in the intraoperative CEUS exploration appear to justify the use of this promising modality.

AB - Conventional ultrasonography (US) has limited accuracy in the detection and characterisation of solid focal liver lesions (FLL). Contrast-enhanced ultrasound (CEUS) significantly improves the diagnostic performance of US in the assessment of FLL. Rare reports of serious adverse events have been reported with CEUS. The rates of adverse reactions reported from the use of ultrasound contrast agents seem comparable to, or lower than, those observed for other imaging modalities that use contrast agents such as computed tomography and magnetic resonance imaging. Improved diagnostic results and diagnostic confidence achieved in conventional CEUS studies of the liver and during the investigational use in the intraoperative CEUS exploration appear to justify the use of this promising modality.

KW - Contrast-enhanced ultrasound (CEUS)

KW - Hepatocellular carcinoma

KW - Intraoperative ultrasonography

KW - Liver cirrhosis

KW - Liver metastases

KW - Liver tumour

UR - http://www.scopus.com/inward/record.url?scp=19444373922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19444373922&partnerID=8YFLogxK

U2 - 10.1517/14740338.4.3.399

DO - 10.1517/14740338.4.3.399

M3 - Article

C2 - 15934848

AN - SCOPUS:19444373922

VL - 4

SP - 399

EP - 401

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

SN - 1474-0338

IS - 3

ER -